Genotyping in rheumatoid arthritis: a game changer in clinical management?

References

• MacGregor AJ, Snieder H, Rigby AS, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis & Rheumatism 2000;43(1):30-7
   PubMed Web of Science ®Google Scholar
• Raychaudhuri S, Sandor C, Stahl EA, et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 2012;44(3):291-6
   PubMed Web of Science ®Google Scholar
• Eyre S, Bowes J, Diogo D, et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet 2012;44(12):1336-40
   PubMed Web of Science ®Google Scholar
• Okada Y, Wu D, Trynka G, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 2014;506(7488):376-81
   PubMed Web of Science ®Google Scholar
• Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.[see comment]. Nature 2007;447(7145):661-78
   PubMed Web of Science ®Google Scholar
• Scott IC, Seegobin SD, Steer S, et al. Predicting the risk of rheumatoid arthritis and its age of onset through modelling genetic risk variants with smoking. PLoS Genet 2013;9(9):e1003808
   Web of Science ®Google Scholar
• Yarwood A, Han B, Raychaudhuri S, et al. A weighted genetic risk score using all known susceptibility variants to estimate rheumatoid arthritis risk. Ann Rheum Dis 2013;74(1):170-6
   Google Scholar
• van de Stadt LA, Witte BI, Bos WH, van Schaardenburg D. A prediction rule for the development of arthritis in seropositive arthralgia patients. Ann Rheum Dis 2013;72(12):1920-6
   Google Scholar
• Nam JL, Ramiro S, Gaujoux-Viala C, et al. Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2014;73(3):516-28
   PubMed Web of Science ®Google Scholar
• Luo L, Peng G, Zhu Y, et al. Genome-wide gene and pathway analysis. Eur J Hum Genet 2010;18(9):1045-53
   Google Scholar
• Eleftherohorinou H, Hoggart CJ, Wright VJ, et al. Pathway-driven gene stability selection of two rheumatoid arthritis GWAS identifies and validates new susceptibility genes in receptor mediated signalling pathways. Hum Mol Genet 2011;20(17):3494-506
   PubMed Web of Science ®Google Scholar
• Hosoya T, Iwai H, Yamaguchi Y, et al. Cell cycle regulation therapy combined with cytokine blockade enhances antiarthritis effects without increasing immune suppression. Ann Rheum Dis 2014. [Epub ahead of print]
   Google Scholar
• Pavy S, Toonen EJ, Miceli-Richard C, et al. Tumour necrosis factor alpha -308G->A polymorphism is not associated with response to TNFalpha blockers in Caucasian patients with rheumatoid arthritis: systematic review and meta-analysis. Ann Rheum Dis 2010;69(6):1022-8
   PubMed Web of Science ®Google Scholar
• Kung TN, Dennis J, Ma Y, et al. RFC1 80G>A is a genetic determinant of methotrexate efficacy in rheumatoid arthritis: a human genome epidemiologic review and meta-analysis of observational studies. Arthritis Rheumatol 2014;66(5):1111-20
   PubMed Web of Science ®Google Scholar
• Cui J, Stahl EA, Saevarsdottir S, et al. Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis. PLoS Genet 2013;9(3):e1003394
   PubMed Web of Science ®Google Scholar
• Odegard S, Landewe R, van der Heijde D, et al. Association of early radiographic damage with impaired physical function in rheumatoid arthritis: a ten-year, longitudinal observational study in 238 patients. Arthritis & Rheumatism 2006;54(1):68-75
   PubMedGoogle Scholar
• Knevel R, Grondal G, Huizinga TW, et al. Genetic predisposition of the severity of joint destruction in rheumatoid arthritis: a population-based study. Ann Rheum Dis 2012;71(5):707-9
   Google Scholar
• Mewar D, Marinou I, Coote AL, et al. Association between radiographic severity of rheumatoid arthritis and shared epitope alleles: differing mechanisms of susceptibility and protection. Ann Rheum Dis 2008;67(7):980-3
   PubMed Web of Science ®Google Scholar
• Knevel R, de Rooy DP, Saxne T, et al. A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis. Arthritis Research & Therapy 2014;16(3):R108
   Google Scholar
• Knevel R, Klein K, Somers K, et al. Identification of a genetic variant for joint damage progression in autoantibody-positive rheumatoid arthritis. Ann Rheum Dis 2014;73(11):2038-46
   PubMed Web of Science ®Google Scholar